Frontier Capital Management’s Aerie Pharmaceuticals AERI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-399,103
Closed -$4.55M 289
2021
Q3
$4.55M Sell
399,103
-10,776
-3% -$158K 0.04% 261
2021
Q2
$6.56M Sell
409,879
-22,494
-5% -$386K 0.05% 259
2021
Q1
$7.73M Sell
432,373
-34,392
-7% -$594K 0.06% 236
2020
Q4
$6.31M Sell
466,765
-55,104
-11% -$666K 0.05% 250
2020
Q3
$6.14M Buy
521,869
+16,023
+3% +$195K 0.05% 248
2020
Q2
$7.47M Buy
505,846
+85,307
+20% +$1.26M 0.07% 240
2020
Q1
$5.68M Sell
420,539
-123,676
-23% -$2.35M 0.06% 230
2019
Q4
$13.2M Sell
544,215
-2,141
-0.4% -$44.3K 0.1% 209
2019
Q3
$10.5M Buy
546,356
+220,293
+68% +$5.05M 0.08% 218
2019
Q2
$9.63M Buy
326,063
+491
+0.2% +$18.9K 0.07% 227
2019
Q1
$15.5M Buy
325,572
+211,699
+186% +$9.32M 0.11% 209
2018
Q4
$4.11M Sell
113,873
-439,372
-79% -$20.6M 0.03% 267
2018
Q3
$34.1M Buy
553,245
+187,810
+51% +$12.1M 0.22% 158
2018
Q2
$24.7M Buy
+365,435
New +$20.4M 0.17% 183

Other funds holding AERI

Frontier Capital Management's AERI Position: Q4 2021 in Review

Frontier Capital Management sold out of Aerie Pharmaceuticals (AERI) in Q4 2021, closing a stake of 399,103 shares — an estimated $4.55M sold.

Frontier Capital Management first reported a position in AERI in Q2 2018 and held it in 14 quarters. The position peaked at $34.1M in Q3 2018. 129 funds tracked by Wall St. Rank hold AERI as of Q4 2021.

  • Frontier Capital Management reported no remaining Aerie Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Frontier Capital Management sold 399,103 Aerie Pharmaceuticals shares in Q4 2021, an estimated $4.55M.
  • Frontier Capital Management first reported a position in Aerie Pharmaceuticals in Q2 2018 and held it in 14 quarters.
  • Frontier Capital Management's Aerie Pharmaceuticals position peaked at $34.1M in Q3 2018.
  • 129 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2021.

Based on Frontier Capital Management's 13F filing for Q4 2021, filed 19 Jan 2022.